Navigation Links
Pearl Therapeutics Completes Phase 2b Study of Glycopyrrolate, Defines Dose-Response Curve and Identifies Optimal Dose of PT001
Date:9/13/2012

REDWOOD CITY, Calif., Sept. 13, 2012 /PRNewswire/ -- Pearl Therapeutics Inc. today announced the completion of a randomized, double-blind Phase 2b dose-ranging study in which six doses of the long-acting muscarinic antagonist (LAMA), glycopyrrolate (GP) ranging from 18 micrograms to 600 nanograms BID were delivered via metered-dose inhaler (GP MDI; PT001) to patients with moderate-to-severe COPD. In this study (NCT01566773) and the previously conducted dose-ranging GP MDI studies, a total of nine descending doses (a 240-fold range) of GP have been evaluated. The results, which Pearl plans to present at appropriate medical meetings in 2013, identify doses that are believed to be the lowest effective and optimal doses of GP MDI. Further, they support progression in combination with BID formoterol fumarate (FF MDI, PT005), the LABA component of Pearl's fixed dose bronchodilator combination PT003 (GFF MDI) towards a Phase 3 program.

"By taking full advantage of the flexibility of our porous-particle-based co-suspension MDI formulation platform, we were able to assess doses of GP MDI as low as 600 nanograms, allowing us to characterize fully the dose-response curve of GP MDI. To our knowledge, this is the first time that doses of a LAMA MDI this low have been able to be studied," commented Colin Reisner, chief medical officer and executive vice president of clinical development for Pearl Therapeutics. "These GP MDI dose-ranging results strengthen our confidence in dose selection of this potent bronchodilator and demonstrate our commitment to satisfying the most stringent regulatory expectations."

"The identification of an optimal BID dose of GP MDI complements Pearl's earlier clinical findings in which the optimal BID dose of FF MDI was determined," added Chuck Bramlage, chief executive officer for Pearl Therapeuti
'/>"/>

SOURCE Pearl Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Anthera Pharmaceuticals Provides Additional Data from the Recently Completed PEARL-SC Study of Blisibimod in the Proposed Phase 3 Population
2. Anthera Updates Phase 3 Plans Following Results from the Phase 2b PEARL-SC Dose Ranging Study of Blisibimod
3. NFLPA and THERAPEARL, LLC Partner to Provide Athletes with Game Changing Innovations in Hot and Cold Pack Therapy
4. Pearl Therapeutics Phase 2b Twice-Daily Dosing Data Suggest Morning and Evening Benefit of PT003 in Patients with COPD
5. Heraeus Launches Remarkably Smooth Venus® Pearl Composite
6. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
7. RNL BIO, a South Korean adult stem cell firm, introduces its autologous stem cell therapeutics in Turkey to treat patients with various intractable diseases
8. Healthpoint Biotherapeutics Initiates Phase III Study of Unique Investigational Cell-Based Therapy for Venous Leg Ulcers
9. Novelos Therapeutics Successfully Completes Second Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
10. Sorbent Therapeutics Presents CLP1001 Phase 2a Study Results at the 16th Annual Meeting of the Heart Failure Society of America
11. Novelos Therapeutics And Academic Collaborators Present Three Posters At 2012 World Molecular Imaging Congress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... , April 17, 2015 Contego Medical, ... Embolic Protection™ filter platform for angioplasty balloon and ... $5.6 million Series B financing round led by ... with a focus on medical devices, biopharmaceuticals, diagnostics ... also included Mountain Group Partners, Lookout Capital and ...
(Date:4/17/2015)... , April 17, 2015  AbbVie Inc. ("AbbVie") (NYSE ... that it has extended the expiration of its exchange offer ... of Pharmacyclics, Inc. to 5 p.m., New York ... On April 17, 2015, AbbVie also voluntarily withdrew its ... Act in order to provide the FTC with additional time ...
(Date:4/17/2015)... Inivata, a Cambridge, England -based ... the 2015 American Association for Cancer Research (AACR) Annual Meeting ... and a poster presentation. Michael Stocum , CEO ... nd . The presentation, entitled Monitoring the ... part of a session on Recent Advances in Diagnostics ...
Breaking Medicine Technology:Contego Medical Closes $5.6 Million in Series B Funding 2Contego Medical Closes $5.6 Million in Series B Funding 3AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc. 2AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc. 3AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc. 4Inivata Co-founder Nitzan Rosenfeld to Present at AACR Annual Meeting 2
... 12, 2011 PLC Systems Inc. (OTCBB: PLCSF), a ... it will demonstrate its innovative new product, RenalGuard®, at ... Percutaneous Cardiovascular Interventions (EAPCI).  More than 11,000 clinicians and ... attend this event, which will take place in Paris, ...
... PHOENIX, May 12, 2011 Altitude Organic Corporation (Pinksheets: ... publicly-traded medical marijuana company, is pleased to announce that ... dispensary owners in Arizona who wish to open their ... acts as a consultant to prospective dispensary owner-affiliates, is ...
Cached Medicine Technology:PLC to Demonstrate RenalGuard® at EuroPCR 2011 2PLC to Demonstrate RenalGuard® at EuroPCR 2011 3Altitude Organic Recruits 10 Arizona Dispensary Applicant Affiliates 2Altitude Organic Recruits 10 Arizona Dispensary Applicant Affiliates 3
(Date:4/17/2015)... April 17, 2015 As a board-certified ... his new offering of platelet-rich plasma (PRP) ... (MOSM) is known for its world-class care of ... extensive surgical experience lacking in many other physicians offering ... treatments are utilized for pain management and rehabilitation. Dr. ...
(Date:4/17/2015)... Most dental patients are not aware ... made overseas by foreign dental laboratories, according to the ... in more than 40 states by their respective state ... Dental Laboratories has created the “What’s In ... about the consequences that could be associated with using ...
(Date:4/17/2015)... Baptist Health and The University of ... agreement designed to transform oncology care in northeast Florida ... to create a joint cancer program to enhance patient ... Baptist MD Anderson Cancer Center is anticipated to open ... for highly coordinated, multidisciplinary cancer care for adults in ...
(Date:4/17/2015)... April 17, 2015 Scientists from ... multicenter team of U.S. and Venezuelan researchers, have ... in humans among an isolated tribe of Yanomami ... Bacterial diversity in the Yanomami, previously unexposed to ... nearly double that of people living in industrialized ...
(Date:4/17/2015)... TX (PRWEB) April 17, 2015 Connie ... specialist and functional medicine advocate with 30 years of ... will be adding another level of service for her ... her website of 10 recommended wellness books with a ... When asked to explain her interest in providing this ...
Breaking Medicine News(10 mins):Health News:Platelet-Rich Plasma, Stem Cell Therapy Now Offered By Dr. Meier At MOSM in Beverly Hills, California 2Health News:Platelet-Rich Plasma, Stem Cell Therapy Now Offered By Dr. Meier At MOSM in Beverly Hills, California 3Health News:National Association Urges Transparency in Dental Industry 2Health News:Baptist Health and MD Anderson Finalize Agreement to Transform Cancer Care in Region 2Health News:Baptist Health and MD Anderson Finalize Agreement to Transform Cancer Care in Region 3Health News:Mount Sinai Scientists Find Unprecedented Microbial Diversity in Isolated Amazonian Tribe Previously Unexposed to Antibiotics or Processed Foods 2Health News:Mount Sinai Scientists Find Unprecedented Microbial Diversity in Isolated Amazonian Tribe Previously Unexposed to Antibiotics or Processed Foods 3Health News:Connie Casad, M.D. Provides Patients Recommended List of Wellness Books on Website 2
... HealthDay Reporter , WEDNESDAY, April 27 (HealthDay News) -- ... were also removed had a lower risk of subsequent ovarian ... or other types of cancer, a new study indicates. ... the researchers analyzed more than 25,000 postmenopausal women aged 50 ...
... HealthDay Reporter , WEDNESDAY, April 27 (HealthDay News) -- ... sugar control, often sending people with type 2 diabetes ... that happens. Now, a new study provides some ... decline dramatically in those who have the bypass surgery, ...
... -- Levels of chemical flame-retardants in the blood of pet ... researchers have found. In the study, Indiana University scientists ... blood of 17 pet dogs who mainly lived indoors. The ... about 2 nanograms per gram. The researchers also found ...
... Widespread demands in Canada for clinical trials for a controversial ... Internet and social media to influence research priorities, according to ... Zamboni, an Italian surgeon, suggested in 2008 that MS was ... by blockages in the brain. He proposed unblocking the veins ...
... , WEDNESDAY, April 27 (HealthDay News) -- Researchers in ... the activity of a single gene in living cells. ... University watched, in real time, the process of gene transcription ... gene converts its DNA information into molecules of messenger RNA ...
... WEDNESDAY, April 27 (HealthDay News) -- Doctors are far more ... an expensive MRI scan if they own or lease such ... School of Medicine researchers also found that after orthopedists bought ... back surgery within six months of seeing the orthopedist for ...
Cached Medicine News:Health News:Removing Ovaries During Hysterectomy Won't Raise Other Health Risks: Study 2Health News:Removing Ovaries During Hysterectomy Won't Raise Other Health Risks: Study 3Health News:New Clues to How Gastric Bypass Surgery Combats Diabetes 2Health News:New Clues to How Gastric Bypass Surgery Combats Diabetes 3Health News:Pet Dogs May Be Exposed to High Levels of Flame Retardants 2Health News:Social media can alter research priorities, according to paper in Nature 2Health News:Researchers Describe Gene Activity in Living Cells 2Health News:When Docs Own MRIs, Back Pain Scans Increase: Study 2Health News:When Docs Own MRIs, Back Pain Scans Increase: Study 3
Bottega Venetas new collection expresses a unique style and determined personality: discreet elegance and refined luxury are the themes that inspire the creation of these new models, destined to beco...
Classic, stylish, and preppy, this collection features men's, women's and unisex styles....
... the elegant and sophisticated woman, ... includes ophthalmic and sunwear styles. ... variety of shapes and colors, ... shapes and complexions. Many styles ...
The Nine West Eyewear collection is positioned to present today's styles with a sharp, edgy contemporary attitude tied into a clean design element....
Medicine Products: